Serum metabolomics as a novel diagnostic approach for gastrointestinal cancer

Biomedical Chromatography

Volumn 26, Issue 5, 2012, Pages 548-558

  Ikeda, Atsuki ^a   Nishiumi, Shin ^a   Shinohara, Masakazu ^a   Yoshie, Tomoo ^a   Hatano, Naoya ^a   Okuno, Tatsuya ^a   Bamba, Takeshi ^b   Fukusaki, Eiichiro ^b   Takenawa, Tadaomi ^a   Azuma, Takeshi ^a   Yoshida, Masaru ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Biomarker; GC MS; Multiple classification analysis; Sensitivity; Specificity

Indexed keywords

AMINO ACIDS; BIOMOLECULES; BODY FLUIDS; DIAGNOSIS; DISEASES; METABOLITES; SENSITIVITY ANALYSIS; TUMORS;

CANCER PATIENTS; CLASSIFICATION ANALYSIS; GASTROINTESTINAL; GC/MS; HEALTHY VOLUNTEERS; METABOLOMICS; MULTIPLE CLASSIFICATION; MULTIPLE CLASSIFICATION ANALYSE; SENSITIVITY; SPECIFICITY;

BIOMARKERS;

2 HYDROXYBUTYRIC ACID; 2 HYDROXYISOVALERIC ACID; 3 (3,4 DIHYDROXYPHENYL) 2 [3 (4 FLUOROPHENYL)PROPYLAMINO] 3 HYDROXYPROPIONIC ACID PYRROLIDINE AMIDE; 3 HYDROXY 2 METHYLPROPIONIC ACID; ALANINE; ALLO ISOLEUCINE; FUMARIC ACID; GLUCURONOIC LACTONE; GLUTAMINE; GLYCERIC ACID; GLYCEROL; GLYCINE; GLYCOLIC ACID; GLYOXYLIC ACID; HYDRACRYLIC ACID; ISOLEUCINE; LACTIC ACID; LEUCINE; MALONIC ACID; OCTANOIC ACID; OXALIC ACID; PARA CRESOL; PHOSPHORIC ACID; PROLINE; PYRUVIC ACID; SERINE; TUMOR MARKER; UNCLASSIFIED DRUG; UNINDEXED DRUG; UREA; VALINE;

AGED; ARTICLE; BLOOD SAMPLING; BODY MASS; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; FEMALE; HUMAN; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABOLOMICS; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SERUM METABOLITE; SERUM METABOLOMICS; STOMACH CANCER; TUMOR LOCALIZATION;

EID: 84859441139     PISSN: 02693879     EISSN: 10990801     Source Type: Journal    
DOI: 10.1002/bmc.1671     Document Type: Article

References (32)

1. Alexandrov T, Decker J, Mertens B, Deelder AM, Tollenaar RA, Maass P, Thiele H. Biomarker discovery in MALDI-TOF serum protein profiles using discrete wavelet transformation. Bioinformatics 2009; 25: 643-649.
2. Asaka M, Takeda H, Sugiyama T, Kato M. What role does Helicobacter pylori play in gastric cancer? Gastroenterology 1997; 113: 56-60.
3. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001; 357: 539-545.
4. Bergqvist AS, Bergqvist M, Brattstrom D, Hesselius P, Larsson A, Brodin O, Wagenius G. Serum p53 autoantibodies as prognostic marker in patients with oesophageal carcinoma. Anticancer Research 2001; 21: 4141-4145.
5. Bjerrum JT, Nielsen OH, Hao F, Tang H, Nicholson JK, Wang Y, Olsen J. Metabonomics in ulcerative colitis: diagnostics, biomarker identification, and insight into the pathophysiology. Journal of Proteome Research 2010; 9: 954-962.
6. Bjorkholm B, Falk P, Engstrand L, Nyren O. Helicobacter pylori: resurrection of the cancer link. Journal of Internal Medicine 2003; 253: 102-119.
7. Doll R, Peto R. The causes of cancer: quantitative estimates of avoidable risks of cancer in the United States today. Journal of the National Cancer Institute 1981; 66: 1191-1308.
8. Eigenbrodt E, Kallinowski F, Ott M, Mazurek S, Vaupel P. Pyruvate kinase and the interaction of amino acid and carbohydrate metabolism in solid tumors. Anticancer Research 1998; 18: 3267-3274.
9. Fujita Y, Nakanishi T, Miyamoto Y, Hiramatsu M, Mabuchi H, Miyamoto A, Shimizu A, Takubo T, Tanigawa N. Proteomics-based identification of autoantibody against heat shock protein 70 as a diagnostic marker in esophageal squamous cell carcinoma. Cancer Letters 2008; 263: 280-290.
10. Groome M, Lindsay J, Ross PE, Cotton JP, Hupp TR, Dillon JF. Use of oesophageal stress response proteins as potential biomarkers in the screening for Barrett's oesophagus. European Journal of Gastroenterology and Hepatology 2008; 20: 961-965.
11. Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, Bodian C, Ullman T. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007; 133: 1099-1105.
12. Hirayama A, Kami K, Sugimoto M, Sugawara M, Toki N, Onozuka H, Kinoshita T, Saito N, Ochiai A, Tomita M, Esumi H, Soga T. Quantitative metabolome profiling of colon and stomach cancer microenvironment by capillary electrophoresis time-of-flight mass spectrometry. Cancer Research 2009; 69: 4918-4925.
13. Hiyama T, Yoshihara M, Tanaka S. Genetic polymorphisms and esophageal cancer risk. International Journal of Cancer 2007; 121: 1643-1658.
14. Isono K, Ochiai T, Okuyama K, Onoda S. The treatment of lymph node metastasis from esophageal cancer by extensive lymphadenectomy. Japanese Journal of Surgery 1990; 20: 151-157.
15. Jemal A, Ward E. Cancer statistics 2010. Atlanta. CA: a Cancer Journal for Clinicians 2010; 60: 277-300.
16. Jonsson P, Johansson ES, Wuolikainen A, Lindberg J, Schuppe-Koistinen I, Kusano M, Sjostrom M, Trygg J, Moritz T, Antti H. Predictive metabolite profiling Applying hierarchal multivariate curve resolution to GC-MS data - a potential tool for multi - parametric diagnosis. Journal of Protein Research 2006; 5: 1407-1414.
17. Leman ES, Schoen RE, Magheli A, Sokoll LJ, Chan DW, Getzenberg RH. Evaluation of colon cancer-specific antigen 2 as a potential serum marker for colorectal cancer. Clinical Cancer Research 2008; 14: 1349-1354.
18. Lu H, Zhou JH, Ma YY, Lu HL, Tang YL, Zhang QY, Zhao CH. Five serum proteins identified using SELDI-TOF-MS as potential biomarkers of gastric cancer. Japanese Journal of Clinical Oncology 2010; 40: 336-342.
19. Ma Y, Liu W, Peng J, Huang L, Zhang P, Zhao X, Cheng Y, Qin H. A pilot study of gas chromatograph/mass spectrometry- based serum metabolic profiling of colorectal cancer after operation. Molecular Bioliogy Report 2010; 37: 1403-1411.
20. Miyashita M, Makino H, Katsuta M, Nomura T, Shinji S, Kashiwabara M, Takahashi K, Kudo M, Ishiwata T, Naito Z, Tajiri T. Cyclo-oxygenase-2 over-expression is associated with human esophageal squamous cell carcinoma. Journal of Nippon Medical School 2006; 73: 308-313.
21. Morikawa T, Kato J, Yamaji Y, Wada R, Mitsushima T, Sakaguchi K, Shiratori Y. Sensitivity of immunochemical fecal occult blood test to small colorectal adenoma. American Journal of Gastroenterology 2007; 102: 2259-2264.
22. Nishiumi S, Shinohara M, Ikeda A, Yoshie T, Hatano N, Kakuyama S, Kutsumi H, Fukusaki E, Azuma T, Takenawa T, Yoshida M. Serum metabolomics as a novel diagnostic approach for pancreatic cancer. Metabolomics 2010; 6: 518-528.
23. Ooi M, Nishiumi S, Yoshie T, Shiomi Y, Kohashi M, Fukunaga K, Nakamura S, Matsumoto T, Hatano N, Shinohara M, Irino Y, Takenawa T, Azuma T, Yoshida M. Inflammation Research 2011, in press.
24. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA: a Cancer Journal for Clinicians 2005; 55: 74-108.
25. Qiu Y, Cai G, Su M, Chen T, Zheng X, Xu Y, Ni Y, Zaho A, Xu LX, Cai S, Jia W. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. Journal of Proteome Research 2009; 8: 4844-4850.
26. Shimada H, Kuboshima M, Shiratori T, Nabeya Y, Takeuchi A, Takagi H, Nomura F, Takiguchi M, Ochiai T, Hiwasa T. Serum anti-myomegalin antibodies in patients with esophageal squamous cell carcinoma. International Journal of Oncology 2007; 30: 97-103.
27. 2 extraction is a key parameter determining the oxygenation status of malignant tumors and normal tissues. International Journal of Oncology 2003; 22: 795-798.
28. Veale RB, Thornley AL, Scott E, Antoni A, Segal I. Quantitation of autoantibodies to cytokeratins in sera from patients with squamous cell carcinoma of the oesophagus. British Journal of Cancer 1988; 58: 767-772.
29. Warburg O. On the origin of cancer cells. Science 1956; 123: 309-314.
30. Wu H, Shen X. Metabolomic study for diagnostic model of oesophageal cancer using gas chromatography/mass spectrometry. Journal of Chromatography B: Analytical Technology in Biomedicine and Life Sciences 2009; 877: 3111-3117.
31. Wu H, Xue R, Tang Z, Deng C, Liu T, Zeng H, Sun Y, Shen X. Metabolomic investigation of gastric cancer tissue using gas chromatography/ mass spectrometry. Analytical and Bioanalytical Chemistry 2010; 396: 1385-1395.
32. Yee YK, Wong BC. Adenocarcinoma of the esophagogastric junction: do we see more or less? Journal of Gastroenterology and Hepatology 2008; 23: 1627-1628.